【YONGTAI 7066 交流专区】永大

icy97

Expiry/Maturity of the securities

YONG TAI BERHAD

Instrument Category	Securities of PLC
Instrument Type	Warrants
Type Of Expiry	Expiry/Maturity of the securities
Mode of Satisfaction of Exercise/Conversion price	Cash
Exercise/ Strike/ Conversion Price	Malaysian Ringgit (MYR) 0.5000
Exercise/ Conversion Ratio	1:1
Settlement Type / Convertible into	Physical (Shares)
Last Date & Time of Trading	05 Jun 2020 05:00 PM
Date & Time of Suspension	09 Jun 2020 09:00 AM
Last Date & Time for Transfer into Depositor's CDS a/c	17 Jun 2020 04:30 PM
Date & Time of Expiry	24 Jun 2020 05:00 PM
Date & Time for Delisting	25 Jun 2020 09:00 AM

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3055387

Attachments YTB_NOTICE TO WARRANTS HOLDERS.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2020

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2020	31 Mar 2019	31 Mar 2020	31 Mar 2019
		$$'000	$$'000	$$'000	$$'000

1	Revenue	7,548	40,061	47,684	90,417
2	Profit/(loss) before tax	-12,023	-3,850	-16,952	-14,915
3	Profit/(loss) for the period	-11,374	-5,255	-17,240	-16,394
4	Profit/(loss) attributable to ordinary equity holders of the parent	-11,374	-5,255	-17,239	-16,394
5	Basic earnings/(loss) per share (Subunit)	-1.19	-1.08	-2.17	-3.38
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.5700		0.9300

icy97

YONG TAI BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Special Issue
Details of corporate proposal	Special Issue of up to 400,000,000 new ordinary shares in Yong Tai Berhad
No. of shares issued under this corporate proposal	19,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.1250
Par Value($$) (if applicable)
Latest issued share capital after the above corporate proposal in the following
Units	985,607,071
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 446,168,532.000
Listing Date	19 Aug 2020

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2020

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2020	30 Jun 2019	30 Jun 2020	30 Jun 2019
		$$'000	$$'000	$$'000	$$'000

1	Revenue	577	9,979	42,606	100,396
2	Profit/(loss) before tax	-22,318	-77,621	-39,269	-92,536
3	Profit/(loss) for the period	-27,514	-62,926	-44,754	-79,320
4	Profit/(loss) attributable to ordinary equity holders of the parent	-27,513	-62,926	-44,752	-79,320
5	Basic earnings/(loss) per share (Subunit)	-2.88	-11.78	-5.35	-15.94
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.5400		0.9300

icy97

YONG TAI BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Special Issue
Details of corporate proposal	Special Issue of up to 400,000,000 new ordinary shares in Yong Tai Berhad
No. of shares issued under this corporate proposal	52,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.1250
Par Value($$) (if applicable)
Latest issued share capital after the above corporate proposal in the following
Units	1,041,045,901
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 455,419,596.000
Listing Date	22 Oct 2020

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2020

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2020	30 Sep 2019	30 Sep 2020	30 Sep 2019
		$$'000	$$'000	$$'000	$$'000

1	Revenue	43,454	29,487	43,454	29,487
2	Profit/(loss) before tax	528	31	528	31
3	Profit/(loss) for the period	437	173	437	173
4	Profit/(loss) attributable to ordinary equity holders of the parent	437	174	437	174
5	Basic earnings/(loss) per share (Subunit)	0.04	0.03	0.04	0.03
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.5300		0.5400

Type	Announcement
Subject	OTHERS
Description	YONG TAI BERHAD (YTB OR COMPANY) i. HEADS OF AGREEMENT BETWEEN YTB AND SHENZEN KANGTAI BIOLOGICAL PRODUCTS CO. LTD (SZKT) IN RELATION TO THE DEVELOPMENT AND EXCLUSIVE COMMERCIALISATION OF COVID-19 INACTIVATED VACCINE IN MALAYIA (PROPOSED COLLABORATION)ii. ADVISORY AND SERVICE AGREEMENT BETWEEN YTB AND KLINSEL SDN BHD (KSB)
The Board of Directors of YTB (“Board”) wishes to announce that on 4 December 2020, YTB had entered the following documents: (i) Heads of Agreement (“HOA”) with SZKT (collectively referred to as the “Parties” and each as a “Party”) to record the Parties’ agreement for a Proposed Collaboration in relation to the development and exclusive commercialisation (i.e. marketing, distribution and sale) of its Inactivated Covid-19 Vaccine in Malaysia; and (ii) Advisory and Service Agreement (“ASA”) with KSB to appoint KSB as the Contract Research Organisation (“CRO”) for the proposed Phase III Clinical Study of a SZKT Covid-19 vaccine to be conducted in Malaysia. The details of the Announcement in relation to HOA and ASA is attached. This announcement is dated 4 December 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3111435

Attachments YTB_Announcement on HOA and ASA_4 Dec 2020 (Final).pdf

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	YONG TAI BERHAD ("YONG TAI" OR THE "COMPANY")PROPOSED PRIVATE PLACEMENT
On behalf of the Board of Directors of Yong Tai, TA Securities Holdings Berhad wishes to announce that the Company proposes to undertake a private placement of up to 20% of the total number of issued shares of the Company to third party investor(s) to be identified later (“Proposed Private Placement”). Further details of the Proposed Private Placement are set out in the attachments below. This announcement is dated 7 December 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3111822

Attachments Yong Tai - Proposed Private Placement.pdf Yong Tai - Proposed Private Placement (Appendix I).pdf

Type	Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID	IQL-07122020-00001
Subject	i. HEADS OF AGREEMENT BETWEEN YTB AND SHENZEN KANGTAI BIOLOGICAL PRODUCTS CO. LTD (SZKT) IN RELATION TO THE DEVELOPMENT AND EXCLUSIVE COMMERCIALISATION OF COVID-19 INACTIVATED VACCINE IN MALAYSIA (PROPOSED COLLABORATION) ii. ADVISORY AND SERVICE AGREEMENT BETWEEN YTB AND KLINSEL SDN BHD (KSB)
Description	Letter Subject or Reference - Heads of Agreement ("HOA") and Advisory and Service Agreement ("ASA")
Query Letter Contents	We refer to your Company's announcement dated 4 December 2020, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Malaysia Securities Berhad with the following additional information for public release:- 1. Whether the Heads of Agreements (“HOA”) and Advisory and Service Agreement (“ASA”) are legally binding to the respective parties; 2. The timeframe to enter into a definitive agreement for the proposals; 3. Information of the development of SZKT’s Covid-19 vaccine (“Vaccine”) including the progress of Phase I and Phase II clinical studies and trials, and the status of the studies/trials todate; 4. To specify the relevant authorities’ approvals required and status of approvals todate, for the following: (i) The Phase III clinical trial for the Vaccine; (ii) The emergency usage of the Vaccine in Malaysia; and (iii) The distribution and sale of the Vaccine in Malaysia. 5. The basis to arrive at the vaccine procurement program numbers of 100 million doses of Vaccine over five year period; and 6. The estimated financial commitment required by the Group for the development of the Vaccine as well as the commercialization of the Vaccine, together with the source of funds.
We refer to the Company's announcement dated 4 December 2020 in relation to the query letter (Ref: IQL-07122020-00001). The Company wishes to furnish additional information in relation to the above matter, as attached. This announcement is dated 8 December 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3111919

Attachments YTB- Reply to Query Letter on HOA and ASA (20201208).pdf

YONG TAI BERHAD

Particulars of substantial Securities Holder

Name	FULL WINNING DEVELOPMENTS LIMITED
Address	Vistra Corporate Services Centre Wickhams Cay II, Road Town Tortola, VG1110 Virgin Islands, British.
Company No.	1891448
Nationality/Country of incorporation	Virgin Islands, British
Descriptions (Class)	ORDINARY SHARE

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	07 Dec 2020	73,208,000	Disposed	Direct Interest
	Name of registered holder	Full Winning Developments Ltd
	Address of registered holder	Vistra Corporate Services Centre, Wickhamas Cay II, Road Town, Tortola, VG1110, British Virgin Islands.
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Disposal of Shares Via Open Market
Nature of interest	Direct Interest
Direct (units)	76,822,000
Direct (%)	7.373
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	76,822,000
Date of notice	09 Dec 2020
Date notice received by Listed Issuer	09 Dec 2020

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	YONG TAI BERHAD ("YONG TAI" OR THE "COMPANY")PROPOSED PRIVATE PLACEMENT
(For consistency, the abbreviations used throughout this announcement shall have the same meanings as defined in the announcement dated 7 December 2020 in relation to the Proposed Private Placement, where applicable, unless stated otherwise or defined herein.) Reference is made to the announcement dated 7 December 2020. On behalf of the Board, TA Securities wishes to announce additional information in relation to the Proposed Private Placement as set out in the attachment below. This announcement is dated 9 December 2020.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3112579

Attachments Yong Tai - Proposed Private Placement (Additional Information).pdf

YONG TAI BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Private Placement
Details of corporate proposal	Private Placement of up to 20% of the issued shares of Yong Tai Berhad
No. of shares issued under this corporate proposal	25,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.3600
Par Value($$) (if applicable)	0.000
Latest issued share capital after the above corporate proposal in the following
Units	1,072,184,364
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 470,062,866.200
Listing Date	23 Dec 2020

YONG TAI BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Private Placement
Details of corporate proposal	Private Placement of up to 20% of the issued shares of Yong Tai Berhad
No. of shares issued under this corporate proposal	50,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.3000
Par Value($$) (if applicable)	0.000
Latest issued share capital after the above corporate proposal in the following
Units	1,122,666,564
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 485,448,626.200
Listing Date	06 Jan 2021

Type	Announcement
Subject	OTHERS
Description	i) HEADS OF AGREEMENT BETWEEN YONG TAI BERHAD ("YTB" OR "COMPANY") AND SHENZEN KANGTAI BIOLOGICAL PRODUCTS CO. LTD ("SZKT") IN RELATION TO THE DEVELOPMENT AND EXCLUSIVE COMMERCIALISATION OF COVID-19 INACTIVATED VACCINE IN MALAYSIA ("PROPOSED COLLABORATION"); ii) INCORPORATION OF A SUBSIDIARY COMPANY, YTB HEALTHCARE SDN BHD
(For consistency, the abbreviation used in this announcement shall have the same meaning defined in the announcements dated 4th December 2020 and 8th December 2020 respectively, where applicable, unless stated otherwise or defined herein) Following our earlier announcements in relation to the Proposed Collaboration dated 4 December 2020 and 8 December 2020, the Board wishes to announce that: - (i) The Company had on 28 December 2020 incorporated a 70% owned-subsidiary, known as YTB Healthcare Sdn Bhd (“YTBH”) for a cash consideration of RM70.00 comprising 70  ordinary shares; (ii) The Company and SZKT have on 6 January 2021, by way of extension letter, agreed to work towards the definitive commercialisation agreement (“Definitive Agreement”) on or before 3 February 2021. All other terms and provisions contained in the HOA shall remain unchanged; (iii) YTBH has on 6 January 2021 entered into a Collaboration Agreement (“CA”) with Tiong Nam Logistics Solutions Sdn Bhd (“Tiong Nam”) to engage Tiong Nam to provide total logistics services which include transportation, warehouse space storage and distribution of the pharmaceutical products such as Covid-19 Vaccine (“Products”); and (iv) YTBH has on 6 January 2021 entered into Service Provider Agreement (“SA”) with Healthcliqs Sdn Bhd (“Healthcliqs”) to engage Heathcliqs as service provider for the provision of services which include, amongst others, promotional sales campaign, marketing activities and virtual sales representation services of the Products. The details of the annoucement are set out in the attachment. This announcement is dated 6 January 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3119172

Attachments YTB_Proposed Collaboration and Incorporation of Subsidiary_20210106.pdf

Type	Announcement
Subject	OTHERS
Description	i) HEADS OF AGREEMENT BETWEEN YONG TAI BERHAD ("YTB" OR "COMPANY") AND SHENZEN KANGTAI BIOLOGICAL PRODUCTS CO. LTD ("SZKT") IN RELATION TO THE DEVELOPMENT AND EXCLUSIVE COMMERCIALISATION OF COVID-19 INACTIVATED VACCINE IN MALAYSIA ("PROPOSED COLLABORATION"); ii) INCORPORATION OF A SUBSIDIARY COMPANY, YTB HEALTHCARE SDN BHD
(For consistency, the abbreviation used in this announcement shall have the same meaning defined in the announcements dated 4th December 2020, 8th December 2020 and 6th January 2021 respectively, where applicable, unless stated otherwise or defined herein) Reference is made to the Company's announcement dated 6 January 2021. The Board wishes to announce additional information on the above subject matter as set out in the attachment below. This announcement is dated 7 January 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3119546

Attachments YTB_Additional Information_20210107.pdf

YONG TAI BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Private Placement
Details of corporate proposal	Private Placement of up to 20% of the issued shares of Yong Tai Berhad
No. of shares issued under this corporate proposal	50,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.3000
Par Value($$) (if applicable)	0.000
Latest issued share capital after the above corporate proposal in the following
Units	1,174,457,964
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 501,881,746.200
Listing Date	27 Jan 2021

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	YONG TAI BERHAD ("YTB" OR "COMPANY")I. PROPOSED ISSUANCE OF UP TO 180,000,000 NEW REDEEMABLE CONVERTIBLE PREFERENCE SHARES IN YTB ("RCPS") AT AN ISSUE PRICE OF RM1.00 PER RCPS ("PROPOSED ISSUANCE OF RCPS"); ANDII. PROPOSED AMENDMENTS TO THE CONSTITUTION OF YTB TO FACILITATE THE ISSUANCE OF RCPS PURSUANT TO THE PROPOSED ISSUANCE OF RCPS,(COLLECTIVELY REFERRED TO AS THE "PROPOSALS")
On behalf of the Board of Directors of YTB, Kenanga Investment Bank Berhad wishes to announce that the Company proposes to undertake the Proposals. Please refer to the attachment for further details. This announcement is dated 28 October 2021.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3204719

Attachments Yong Tai Berhad - Proposals (28 October 2021).pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2021

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2021	30 Sep 2020	30 Sep 2021	30 Sep 2020
		$$'000	$$'000	$$'000	$$'000

1	Revenue	4,856	43,454	4,856	43,454
2	Profit/(loss) before tax	-5,476	528	-5,476	528
3	Profit/(loss) for the period	-5,560	437	-5,560	437
4	Profit/(loss) attributable to ordinary equity holders of the parent	-5,560	437	-5,560	437
5	Basic earnings/(loss) per share (Subunit)	-0.41	0.04	-0.41	0.04
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.4200		0.4300

icy97

YONG TAI BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Others
Details of corporate proposal	ISSUANCE OF 92,000,000 NEW YONG TAI BERHAD ("YTB") SHARES TO SETTLE A TOTAL OF RM46,000,000 DEBT OWING TO CREDITORS BY YTB AND/OR ITS SUBSIDIARIES ("DEBT SETTLEMENT")
No. of shares issued under this corporate proposal	92,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.5000
Par Value($$) (if applicable)	Malaysian Ringgit (MYR)   0.000
Latest issued share capital after the above corporate proposal in the following
Units	378,097,001
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 649,658,415.800
Listing Date	15 Sep 2022

icy97

Notice of Interest Sub. S-hldr (Section 137 of CA 2016)

YONG TAI BERHAD

Particulars of Substantial Securities Holder

Name	CITY MALL SDN BHD
Address	Level P2 City Plaza, 21 Jalan Tebrau, Johor Bahru 80300 Johor Malaysia.
Company No.	99626-A
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	ORDINARY SHARE
Name of registered holder	CITY MALL SDN BHD
Address of registered holder	Level P2 City Plaza, 21 Jalan Tebrau, 80300 Johor Bahru, Johor

Date interest acquired & no of securities acquired
Date interest acquired	12 Sep 2022
No of securities	20,000,000
Circumstances by reason of which Securities Holder has interest	Issuance of new YONG TAI BERHAD (YTB) shares to settle debt owing to creditor by YTB and/or its subsidiaries (Debt Settlement)
Nature of interest	Direct Interest
Total no of securities after change
Direct (units)	20,000,000
Direct (%)	5.29
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Date of notice	14 Sep 2022
Date notice received by Listed Issuer	15 Sep 2022

Engineer

icy97 发表于 15-9-2022 08:26 AM

永太的马六甲发展计划看来已经失败

icy97

YONG TAI BERHAD

Date of change	01 Sep 2023
Name	MR LAM SHUH POW
Age	43
Gender	Male
Nationality	Malaysia
Type of change	Resignation
Designation	Chief Financial Officer
Reason	Personal Development

icy97

YONG TAI BERHAD

Date of change	17 Oct 2023
Name	MR TAN YOONG WEI
Age	39
Gender	Male
Nationality	Malaysia
Type of change	Resignation
Designation	Chief Operating Officer
Reason	Due to personal reason

icy97

YONG TAI BERHAD

Particulars of substantial Securities Holder

Name	DATUK WIRA BOO KUANG LOON
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	ORDINARY SHARE

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	04 Mar 2024	4,800,000	Acquired	Direct Interest
	Name of registered holder	Maybank Nominees (Tempatan) Sdn Bhd Pledged Securities Account for Boo Kuang Loon
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	ACQUISITION OF SHARES VIA OPEN MARKET
Nature of interest	Direct Interest
Direct (units)	23,750,026
Direct (%)	6.281
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	23,750,026
Date of notice	04 Mar 2024
Date notice received by Listed Issuer	05 Mar 2024

Remarks :

1) Percentage of shares acquired (Direct Interest) = 1.269%